An invited commentary on this study, also published in JAMA Ophthalmology, challenges the idea that the increased risk of NAION among semaglutide users resulted directly from the medication
Who Qualifies in Canada Eligibility depends on which brand (and which indication) is on the table: Ozempic / Rybelsus (on-label): adults with type 2 diabetes needing improved glycemic control, often as a second-line agent after metformin
Following its secretion from gut endocrine cells, GLP-2 promotes the absorption of nutrients through distinct mechanisms of action [66]
We have lots of observational data on AD and GLP1s
Sometimes a lower dose with better adherence, fewer side effects, and consistent use outperforms a higher dose that patients take inconsistently due to adverse effects
Cardioprotective A study found that semaglutide reduced the risk of cardiovascular-related death by 29% (10)